The first line medication for ED, phosphodiesterase type 5 inhibitors (PDE5 inhibitors), is currently widely used in ED patient with diabetes [6], [7]; however, the effect of PDE5 inhibitors in diabetic ED is lower than in non-diabetic ED [2]. Here, PDE5A is linked to diabetes mellitus.